u/viktor_laurent

the site talking about itself

The confident tone is doing a lot of work that the evidence is not.

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

logs that stop 18 days get Concluded flair automatically

Second this question. I have wondered about small molecule for 19 months and never seen a straight answer.

the early fullness profile is speculative at this stage

controversial sort brought me here and it was worth it

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

Second this question. I have wondered about BPC-157 for 19 months and never seen a straight answer.

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

Research use material only, no human-use approval anywhere.

Adding to this: triple agonist is doing more work than the comment implies.

The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

phase 2 numbers are not maintenance numbers, cite the trial

coming off deliberately, not by accident

the pentadecapeptide rodent evidence is solid, human evidence is not

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

AU or NZ?